These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


440 related items for PubMed ID: 15849048

  • 1. Successful treatment of Staphylococcus epidermidis prosthetic valve endocarditis with linezolid after failure of treatment with oxacillin, gentamicin, rifampicin, vancomycin, and fusidic acid regimens.
    de Feiter PW, Jacobs JA, Jacobs MJ, Vink C, van der Geest S.
    Scand J Infect Dis; 2005; 37(3):173-6. PubMed ID: 15849048
    [Abstract] [Full Text] [Related]

  • 2. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
    Wareham DW, Abbas H, Karcher AM, Das SS.
    J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
    [Abstract] [Full Text] [Related]

  • 3. Treatment of vancomycin-intermediate Staphylcoccus aureus endocarditis with linezolid.
    Leung KT, Tong MK, Siu YP, Lam CS, Ng HL, Lee HK.
    Scand J Infect Dis; 2004 Apr; 36(6-7):483-5. PubMed ID: 15307573
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
    Corne P, Marchandin H, Macia JC, Jonquet O.
    Scand J Infect Dis; 2005 Apr; 37(11-12):946-9. PubMed ID: 16308242
    [Abstract] [Full Text] [Related]

  • 6. Endocarditis due to vancomycin-resistant Enterococcus raffinosus successfully treated with linezolid: case report and review of literature.
    Jasovich A, Ganaha MC, Ebi C, García RD, Blanco MA, Lopardo H.
    Rev Argent Microbiol; 2008 Apr; 40(4):204-7. PubMed ID: 19213241
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of vancomycin-intermediate Staphylococcus aureus (VISA) endocarditis with linezolid.
    Balkhair A, Al Muharrmi Z, Darwish L, Farhan H, Sallam M.
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e227-9. PubMed ID: 20005763
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Linezolid-based therapy in Staphylococcus epidermidis endocarditis.
    Mylona E, Fanourgiakis P, Vryonis E, Golfinopoulou S, Skoutelis A, Platsouka E, Chatzis N.
    Int J Antimicrob Agents; 2007 May; 29(5):597-8. PubMed ID: 17229555
    [No Abstract] [Full Text] [Related]

  • 17. Management of infections of osteoarticular prosthesis.
    Barberán J.
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():93-101. PubMed ID: 16669932
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rapidly destructive Staphylococcus epidermidis endocarditis.
    Zinkernagel AS, Speck RF, Ruef C, Zingg W, Berger-Bachi B, Springer B.
    Infection; 2005 Jun; 33(3):148-50. PubMed ID: 15940416
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.